Compare AU
Compare IXJ vs. ROYL
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the S&P Global 1200 Healthcare (IXJ) and the BetaShares Global Royalties ETF (ROYL). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
IXJ | ROYL | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 241 | 7 |
Median incremental investment | $1,000.00 | $700.30 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,695.72 | $1,678.60 |
Average age group | 26 - 35 | > 35 |
Key Summary
IXJ | ROYL | |
|---|---|---|
Strategy | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks | ROYL.AX was created on 2022-09-09 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The investment objective of the Fund is to provide an investment return that aims to track the performance of the Solactive Global Royalties Index (the Index), before taking into account fees and expenses. |
Top 3 holdings | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) | ARM HOLDINGS PLC (12.89 %) WHEATON PRECIOUS METALS CORP (11.03 %) TEXAS PACIFIC LAND CORP (10.48 %) |
Top 3 industries | Other (99.98 %) Communication Services (0.02 %) | Other (49.57 %) Information Technology (17.42 %) Energy (14.55 %) |
Top 3 countries | United States (99.97 %) | United States (41.70 %) Canada (31.36 %) United Kingdom of Great Britain and Northern Ireland (10.92 %) |
Management fee | 0.46 % | 0.69 % |
Key Summary
IXJ | ROYL | |
|---|---|---|
Issuer | iShares | BetaShares |
Tracking index | S&P Global 1200 Healthcare Sector Index - AUD | Solactive Global Royalties Index - AUD - Benchmark TR Net |
Asset class | ETF | ETF |
Management fee | 0.46 % | 0.69 % |
Price | $141.31 | $10.94 |
Size | $1.380 billion | $9.731 million |
10Y return | 128.27 % | N/A |
Annual distribution yield (5Y) | 1.26 % | 1.27 % |
Market | ASX | ASX |
First listed date | 11/03/2009 | 12/09/2022 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IXJ | ROYL | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 241 | 7 |
Median incremental investment | $1,000.00 | $700.30 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,695.72 | $1,678.60 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
IXJ | ROYL | |
|---|---|---|
Pros |
|
|
Cons |
|
|
IXJ | ROYL |
|---|---|
Lower exposure to AU market | Higher exposure to AU market |
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |